Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
200 patients around the world
Available in Brazil
Oswaldo Cruz Foundation
1Research sites
200Patients around the world
This study is for people with
Gonorrhea
Hiv
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Individuals assigned male at birth (cisgender or transgender men), transgender women, or travestis who have sex with men.
Age ≥18 years.
Living with HIV or currently using HIV pre-exposure prophylaxis (PrEP) for at least 6 months.
History of at least one bacterial sexually transmitted infection (chlamydia, gonorrhea, or syphilis) in the past 12 months (laboratory-confirmed or self-reported).
Willing and able to provide informed consent.
Known allergy or hypersensitivity to doxycycline or other tetracycline-class antibiotics.
Current use of medications that may significantly interact with doxycycline or are contraindicated, including systemic retinoids, barbiturates, carbamazepine, or phenytoin.
Sites
Instituto Nacional de Infectologia Evandro Chagas
Recruiting
Av. Brasil, 4365 - Manguinhos, Rio de Janeiro - RJ, 21040-360
